<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-furosemide.xml</id>
  <title>Recalls Watch: Furosemide</title>
  <link rel="self" href="https://recalls.watch/feed/substance-furosemide.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-04-29T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98628/</id>
    <title>Leading Pharma, LLC: Furosemide Tablets</title>
    <link href="https://recalls.watch/recall/fda/98628/"/>
    <updated>2026-04-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98289/</id>
    <title>Graviti Pharmaceuticals Private Limited: Furosemide Tablets</title>
    <link href="https://recalls.watch/recall/fda/98289/"/>
    <updated>2026-01-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Substance</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
